Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5

Next Generation Sequencing for Clinical Diagnostics-Principles and Application to Targeted Resequencing for Hypertrophic Cardiomyopathy: A Paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology - ScienceDirect

Past Events

Genomic medicine: cracking genomes to cure 'incurable' diseases

Frontiers Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease

Genomics and epigenetics link to DNA structure Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Cool Companies - Connect San Diego

The road from next-generation sequencing to personalized medicine

AI in Genomics and Reporting for Clinical Practice

Frontiers From the patient to the population: Use of genomics for population screening

Frontiers Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes

Next generation sequencing and its clinical applications - Novogene

Sue Ann Molero on LinkedIn: #ngs #spatial #transcriptomics